发明名称 N6 heterocyclic 5'-thio substituted adenosine derivatives
摘要 A N6 heterocyclic 5' modified adenosine derivative has the formula wherein: X1 is S, S(O) or S(O)2 ; R1 is a monocyclic or polycyclic heterocyclic group containing from 3 to 15 carbon atoms wherein at least one carbon atom is substituted with an atom or molecule selected from the group consisting of N, O, P and S(O)0-2 wherein R1 does not contain an epoxide group and R1 is not linked to the NH group be a heterocyclyl nitrogen atom; R2 is hydrogen, halo, CF3, or cyano; R3 and R4 are each independently hydrogen, (CO)-R', or -(CO)-R"; R' and R" are as defined in the specification; R5 is optionally substituted alkyl, alkenyl, alkynyl, heterocyclyl, aryl or heteroaryl; The compound is an adenosine A1 receptor partial or full agonist, and is useful for modifying cardiac activity, modifying adipocyte function and treating central nervous system disorders, diabetic disorders and obesity.
申请公布号 NZ514777(A) 申请公布日期 2004.01.30
申请号 NZ20000514777 申请日期 2000.12.01
申请人 CV THERAPEUTICS, INC 发明人 ZABLOCKI, JEFF A;VARKHEDKAR, VAIBHAV;BELARDINELLI, LUIZ;PALLE, VENKATA P;IBRAHIM, PRABHA N
分类号 C07H19/167;A61K9/08;A61K9/20;A61K31/7076;A61P3/04;A61P3/10;A61P9/00;A61P9/04;A61P9/10;A61P25/00;A61P25/08;A61P43/00;C07H19/16;(IPC1-7):C07H19/16;A61K31/707 主分类号 C07H19/167
代理机构 代理人
主权项
地址